Market Tracker

10/23 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

58.53
Delayed Data
As of Oct 23
 -0.50 / -0.85%
Today’s Change
37.35
Today|||52-Week Range
63.77
+51.24%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close59.03
Today’s open59.12
Day’s range58.16 - 59.29
Volume808,752
Average volume (3 months)855,586
Market cap$5.2B
Dividend yield--
Data as of 4:00pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-55.24%
Earnings growth (this year)-48.04%
Earnings growth (next 5 years)-13.59%
Revenue growth (last year)-24.12%
P/E ratioNM
Price/Sales223.72
Price/Book16.29

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp-0.17-0.35%
TECHBio-Techne Corp-0.37-0.30%
JUNOJuno Therapeutics In...+1.42+3.25%
BLUEbluebird bio Inc-2.20-1.54%
Data as of 3:59pm ET, 10/23/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$15.0M
Annual profit (last year)-$141.1M
Net profit margin-940.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Director, Chief Executive &
Financial Officer
Kevin Charles Gorman
Chief Research Officer
Dimitri E. Grigoriadis
Corporate headquarters
San Diego, California

Forecasts